Tags: Drug.

Lenvatinib (E7080) is a multi-kinase inhibitor that is being investigated for the treatment of various types of cancer by Eisai Co. It inhibits both VEGFR2 and VEGFR3 kinases.

Lenvatinib_skeletal.svg
ATC prefix
none
CAS number
417716-92-8
ChEBI
816009
FDA UNII code
EE083865G2
IUPAC name
4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide
PubChem
9823820

Loading...

This page contains content from the copyrighted Wikipedia article "Lenvatinib"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.